CO2 Challenge for Anxiety Disorders

CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy

Recruiting N/A Interventional Study
Obsessive-Compulsive Disorder Post Traumatic Stress Disorder Generalized Anxiety Disorder Social Anxiety Disorder Panic Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
600 (estimated)
Sponsor
Jasper A. Smits · Other
Who this trial is looking for

This trial is looking for adults with certain anxiety disorders to help evaluate a new test that uses CO2 exposure. Participants will undergo a simple CO2 challenge to see if it can help determine if exposure therapy would be beneficial for them.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with an anxiety disorder.
  • I am between 18 and 70 years old.
  • I can provide informed consent for the study.
  • I speak English well.
  • I have an anxiety severity score of 8 or more.

You may not be able to join if

  • I have had a bipolar disorder or psychotic disorder.
  • I have had any substance use disorder in the past 6 months.
  • I have been actively suicidal in the past 6 months.
  • I have a serious cognitive impairment.
  • I have certain medical conditions that prevent CO2 inhalation.
  • I am currently pregnant or breastfeeding.
  • I am undergoing treatment for my anxiety disorder right now.
  • I started new medication within the last 8 weeks.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

Anxiety-, obsessive-compulsive and trauma- and stressor-related disorders reflect a significant public health problem. This study is designed to evaluate the predictive power of a novel biomarker based on a CO2 challenge, thus addressing the central question "can this easy-to-administer assay aid clinicians in deciding whether or not to initiate exposure-based therapy?"

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * A primary DSM-5 diagnosis of panic disorder (with or without an agoraphobia diagnosis), social anxiety disorder, generalized anxiety disorder, obsessive-compulsive disorder, or post-traumatic stress disorder as assessed by the Structured Clinical Interview for the DSM-5 (SCID-…
Contacts

No contact information available.